Tumor cells with constitutively activated K-ras oncogenic signaling have upregulated PKM2, which is mandatory for accumulating phosphoenolpyruvate (PEP), its shunting to an alternative glycolytic pathway and utilization for anabolic processes [106]. This evidence concerns the gene PKM and neoplasm.